PRECISION OPTICS CORPORATION, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
PRECISION OPTICS CORPORATION, INC. (POCI) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.63 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-05-13
- PRECISION OPTICS CORPORATION, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00.
- PRECISION OPTICS CORPORATION, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- PRECISION OPTICS CORPORATION, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $2.63M.
- PRECISION OPTICS CORPORATION, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $133.65K.
- PRECISION OPTICS CORPORATION, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $133.65K.
- PRECISION OPTICS CORPORATION, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $2.63M 10-Q · filed 2026-05-13 | $2.77M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $2.63M 10-Q · filed 2026-02-17 | $2.77M derived: sum of 3 quarters · filed 2026-02-17 | $2.77M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-09-30 | $2.63M 10-Q · filed 2025-11-13 | $2.77M derived: sum of 2 quarters · filed 2025-11-13 | $2.77M derived: sum of 3 quarters · filed 2026-05-13 | $2.77M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | $133.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $133.65K derived: sum of 2 quarters · filed 2026-05-13 | $133.65K derived: sum of 3 quarters · filed 2026-05-13 | $133.65K 10-K · filed 2025-09-29 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $0.00 10-Q · filed 2026-02-17 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $0.00 10-K · filed 2025-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |